Bio-Path Stock Surge Shocks Shorts

BPTH has been an attractive target for short sellers this year

by Karee Venema

Published on Apr 15, 2019 at 10:49 AM
Updated on Apr 15, 2019 at 11:45 AM

The shares of Bio-Path Holdings Inc (NASDAQ:BPTH) jumped more than 34% out of the gate, marking the biotech's first trek above the round $20 mark since April 3. Boosting the shares is Bio-Path's request to the Securities and Exchange Commission (SEC) to withdraw a stock offering, after issuing a prospectus filing in March.

More recently, BPTH stock has accelerated this upside, gaining 53.8% to trade at $24.07, bringing its year-to-date gain to 553%. The shares gapped to an annual high of $73.52 on March 7, thanks to some positive data for the company's experimental cancer drug, but quickly pulled back to the $15.50 region -- site of its 200-day moving average. The equity is now above its 20-day moving average, which briefly served as resistance in late March.

Short sellers are likely feeling the heat during today's surge. Short interest has more than tripled year-to-date, and the 428,405 shares currently sold short represent a healthy 18.1% of BPTH's available float.

 

From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Race for Pot Profits Is On
The race for marijuana profits is on... and one up-and-comer is taking the "Buffett" approach to profits.
2 Stocks Sinking on Healthcare Sector Uncertainty
Both names are seeing heavier-than-usual options activity
Bear Note Pushes Cronos Group Stock Lower
BofA-Merrill Lynch just initiated coverage with an "underperform" rating
The Race for Pot Profits Is On
The race for marijuana profits is on... and one up-and-comer is taking the "Buffett" approach to profits.